开能健康
(300272)
| 流通市值：27.72亿 | | | 总市值：37.12亿 |
| 流通股本：4.31亿 | | | 总股本：5.77亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 789,047,614.73 | 602,535,095.09 | 923,048,403.97 | 900,918,924.98 |
| 结算备付金 | 0 | 0 | - | 0 |
| 拆出资金 | 0 | 0 | - | 0 |
| 衍生金融资产 | 0 | 0 | - | 0 |
| 应收票据及应收账款 | 221,821,831.57 | 238,478,439.86 | 218,644,876.84 | 232,433,470.6 |
| 其中：应收票据 | 10,085,743.12 | 8,623,212.26 | 12,669,335 | 12,910,676.97 |
| 应收账款 | 211,736,088.45 | 229,855,227.6 | 205,975,541.84 | 219,522,793.63 |
| 应收款项融资 | 0 | 0 | - | 0 |
| 预付款项 | 24,222,561.72 | 16,582,552.58 | 20,566,337.51 | 19,795,524.56 |
| 应收保费 | 0 | 0 | - | 0 |
| 应收分保账款 | 0 | 0 | - | 0 |
| 应收分保合同准备金 | 0 | 0 | - | 0 |
| 其他应收款合计 | 4,260,346.29 | 7,678,803.36 | 6,269,830.9 | 7,272,195.53 |
| 其中:应收利息 | 0 | 0 | - | 0 |
| 应收股利 | 0 | 0 | - | 0 |
| 买入返售金融资产 | 0 | 0 | - | 0 |
| 存货 | 255,906,262.84 | 253,991,509.81 | 262,154,033.48 | 268,040,405.73 |
| 合同资产 | 0 | 0 | - | 0 |
| 一年内到期的非流动资产 | 3,166,591.98 | 3,021,332.19 | 1,522,904.06 | 2,699,406.92 |
| 其他流动资产 | 16,661,050.25 | 16,391,204.21 | 13,900,259.16 | 19,415,272.59 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,420,086,259.38 | 1,328,711,077.81 | 1,446,106,841.8 | 1,450,575,395.85 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | 0 | - | 0 |
| 债权投资 | 0 | 0 | - | 0 |
| 其他债权投资 | 0 | 0 | - | 0 |
| 长期应收款 | 15,490,934.64 | 15,888,954.8 | 18,551,103.75 | 19,182,467.69 |
| 长期股权投资 | 854,193,914.44 | 863,407,469.96 | 874,740,868.06 | 874,353,567.39 |
| 其他权益工具投资 | 234,276.63 | 234,276.63 | 234,276.63 | 234,276.63 |
| 其他非流动金融资产 | 6,865,190.1 | 6,865,190.1 | 6,865,190.1 | 6,865,190.1 |
| 投资性房地产 | 0 | 0 | - | 0 |
| 固定资产 | 312,610,384.5 | 305,573,045.63 | 286,142,368.59 | 301,725,037.54 |
| 在建工程 | 39,210,147.28 | 48,464,636.23 | 62,708,546.23 | 44,459,818.87 |
| 生产性生物资产 | 0 | 0 | - | 0 |
| 油气资产 | 0 | 0 | - | 0 |
| 使用权资产 | 67,263,836.32 | 73,718,741.68 | 41,117,925.08 | 47,376,496.56 |
| 无形资产 | 85,724,677.52 | 87,968,593.27 | 89,908,764.12 | 75,767,568.89 |
| 开发支出 | 0 | 0 | - | 0 |
| 商誉 | 150,867,984.95 | 150,867,984.95 | 152,269,368.95 | 152,269,368.95 |
| 长期待摊费用 | 29,208,706.12 | 24,056,580.72 | 15,203,833.13 | 9,364,009.58 |
| 递延所得税资产 | 36,246,055.7 | 38,504,360.57 | 31,886,178.78 | 29,714,628.88 |
| 其他非流动资产 | 12,680,977.34 | 12,077,959.93 | 4,706,036.77 | 2,727,864.88 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,610,597,085.54 | 1,627,627,794.47 | 1,584,334,460.19 | 1,564,040,295.96 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,030,683,344.92 | 2,956,338,872.28 | 3,030,441,301.99 | 3,014,615,691.81 |
| 流动负债: | | | | |
| 短期借款 | 585,476,378.67 | 574,838,290.68 | 774,787,214.83 | 761,719,872.08 |
| 向中央银行借款 | 0 | 0 | - | 0 |
| 吸收存款及同业存放 | 0 | 0 | - | 0 |
| 拆入资金 | 0 | 0 | - | 0 |
| 交易性金融负债 | 0 | 0 | - | 0 |
| 衍生金融负债 | 0 | 0 | - | 0 |
| 应付票据及应付账款 | 214,550,677.66 | 202,115,648.35 | 233,738,785.36 | 237,765,604.7 |
| 其中：应付票据 | 0 | 0 | 20,410,722.6 | 15,136,770.19 |
| 应付账款 | 214,550,677.66 | 202,115,648.35 | 213,328,062.76 | 222,628,834.51 |
| 预收款项 | 0 | 0 | - | 0 |
| 合同负债 | 46,168,274.81 | 36,004,936.76 | 28,982,923.73 | 27,912,307.46 |
| 卖出回购金融资产款 | 0 | 0 | - | 0 |
| 应付手续费及佣金 | 0 | 0 | - | 0 |
| 应付职工薪酬 | 42,475,053.08 | 62,629,319.4 | 35,192,723.02 | 27,937,927.86 |
| 应交税费 | 16,410,705.81 | 13,689,696.56 | 12,399,181.87 | 13,889,905.53 |
| 其他应付款合计 | 86,973,884.05 | 91,508,389.39 | 74,564,892.21 | 75,690,440.7 |
| 其中:应付利息 | 0 | 0 | - | 0 |
| 应付股利 | 161,200 | 161,594 | 165,978 | 167,277 |
| 应付分保账款 | 0 | 0 | - | 0 |
| 保险合同准备金 | 0 | 0 | - | 0 |
| 代理买卖证券款 | 0 | 0 | - | 0 |
| 代理承销证券款 | 0 | 0 | - | 0 |
| 一年内到期的非流动负债 | 152,433,492.37 | 118,117,705.77 | 64,896,368.25 | 68,892,245.57 |
| 其他流动负债 | 6,220,364.02 | 4,822,768.55 | 5,091,621.5 | 5,131,361.61 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,150,708,830.47 | 1,103,726,755.46 | 1,229,653,710.77 | 1,218,939,665.51 |
| 非流动负债: | | | | |
| 长期借款 | 62,437,208.64 | 65,511,233.27 | 12,138,225 | 12,271,341.25 |
| 应付债券 | 188,241,925.54 | 184,243,041.89 | 180,194,364.15 | 176,915,477.27 |
| 优先股 | 0 | 0 | - | 0 |
| 永续债 | 0 | 0 | - | 0 |
| 租赁负债 | 46,075,494.98 | 52,230,311.57 | 30,416,514.31 | 33,274,702.86 |
| 长期应付款 | 132,408,242 | 132,731,541.52 | 136,332,520.02 | 137,399,671.3 |
| 长期应付职工薪酬 | 0 | 0 | - | 0 |
| 预计负债 | 6,628,920.9 | 6,639,302.9 | 2,933,475.9 | 2,965,314.9 |
| 递延收益 | 24,080,212.24 | 24,245,920.28 | 21,903,700 | 22,772,200 |
| 递延所得税负债 | 74,540,470.72 | 75,913,937.58 | 75,334,128.76 | 78,128,846.02 |
| 其他非流动负债 | 0 | 0 | - | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 534,412,475.02 | 541,515,289.01 | 459,252,928.14 | 463,727,553.6 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,685,121,305.49 | 1,645,242,044.47 | 1,688,906,638.91 | 1,682,667,219.11 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 577,217,911 | 577,217,911 | 577,217,911 | 577,217,911 |
| 其他权益工具 | 80,978,319.82 | 80,979,617.1 | 80,996,481.69 | 80,996,481.69 |
| 资本公积 | 87,532,290.87 | 87,531,456.1 | 79,604,489.48 | 73,029,481.31 |
| 减:库存股 | 57,125,394.88 | 57,128,873.04 | 57,173,583.56 | 57,173,583.56 |
| 其他综合收益 | 14,943,280.97 | 16,235,210.61 | 13,717,488.78 | 15,742,844.37 |
| 专项储备 | 0 | 0 | - | 0 |
| 盈余公积 | 123,247,702.49 | 123,247,702.49 | 121,601,855.98 | 121,601,855.98 |
| 一般风险准备 | 0 | 0 | - | 0 |
| 未分配利润 | 419,449,959.89 | 394,639,089.72 | 436,429,325.77 | 437,549,296.46 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,246,244,070.16 | 1,222,722,113.98 | 1,252,393,969.14 | 1,248,964,287.25 |
| 少数股东权益 | 99,317,969.27 | 88,374,713.83 | 89,140,693.94 | 82,984,185.45 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,345,562,039.43 | 1,311,096,827.81 | 1,341,534,663.08 | 1,331,948,472.7 |
| 负债和股东权益合计 | 3,030,683,344.92 | 2,956,338,872.28 | 3,030,441,301.99 | 3,014,615,691.81 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-29 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |